
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cure Kids Ventures (CKV) is a seed and early-stage investment fund established in 2008 and based in New Zealand. The firm is dedicated to the commercialization of innovations in products and services that can significantly benefit child health. CKV is owned by the Cure Kids Foundation, which stands as the largest private funder of child health research in New Zealand. This ownership provides CKV with a unique position in the market, allowing it to leverage substantial resources and expertise in the healthcare sector.
As of now, CKV manages a portfolio of 17 companies and has launched its third fund to continue its investment activities. The firm has built a reputation as a knowledgeable and value-added investor, particularly in the healthcare and biotech sectors. Its office is located in Auckland, New Zealand, and it actively seeks to support emerging companies that align with its mission of enhancing child health.
Cure Kids Ventures invests primarily in emerging healthcare companies within New Zealand that have the potential to positively impact child health. The fund's investment strategy encompasses various sectors, including medical devices, medications, diagnostics, health information, and healthcare delivery systems. CKV's focus on these areas reflects its commitment to supporting innovations that can lead to significant improvements in child health outcomes.
The firm typically engages in pre-seed and seed stage investments, providing not only capital but also industry-specific expertise and access to valuable networks. CKV's investment thesis emphasizes the importance of partnering with companies that are dedicated to developing solutions in healthcare that can directly benefit children. This targeted approach allows CKV to maximize its impact in the healthcare sector.
Cure Kids Ventures has invested in a diverse range of notable companies, including:
CKV has also achieved notable exits, including:
Matthew McMahon: Chief Investment Manager at Cure Kids Ventures, Matthew has extensive experience in venture capital and healthcare investments. He has been instrumental in guiding the firm's investment strategy.
Franceska Banga: Chair of the Board, Franceska brings a wealth of knowledge from her background in governance and investment, having held various leadership roles in the sector.
Howard Moore: Director at CKV, Howard has a strong track record in healthcare investments and provides valuable insights into the firm's portfolio management.
Frances Soutter: Director, Frances has significant experience in venture capital and is focused on identifying promising healthcare innovations.
Matthew Payton: Director, Matthew specializes in early-stage investments and has a keen interest in supporting companies that enhance child health.
To pitch to Cure Kids Ventures, founders should send their proposals via email to info@curekidsventures.co.nz. It is important to include a comprehensive deck that outlines the business model, market opportunity, and how the innovation will benefit child health. While there is no specified response time, founders should expect a thorough review process.
In recent months, Cure Kids Ventures has launched its third fund, aimed at continuing its investment activities in the healthcare sector. This new fund reflects CKV's ongoing commitment to supporting innovations that benefit child health.
The firm remains active in the venture capital landscape, focusing on emerging healthcare companies in New Zealand. Notable portfolio companies continue to develop solutions that address critical needs in child health.
What are Cure Kids Ventures' investment criteria?
Cure Kids Ventures focuses on seed and early-stage investments in healthcare companies that can positively impact child health. The firm looks for innovations in medical devices, medications, diagnostics, and healthcare delivery systems.
How can I apply or pitch to Cure Kids Ventures?
Founders can pitch their ideas by sending an email to info@curekidsventures.co.nz. It is advisable to include a detailed business plan and information about how the innovation will benefit child health.
What makes Cure Kids Ventures different from other investors?
Cure Kids Ventures is unique due to its ownership by the Cure Kids Foundation, which is the largest private funder of child health research in New Zealand. This connection provides CKV with extensive resources and a strong commitment to child health.
What is the geographic scope of Cure Kids Ventures?
The firm primarily invests in companies based in New Zealand, focusing on innovations that can enhance child health within the region.
What is the typical check size for investments?
While specific check sizes are not disclosed, CKV typically invests at the seed and pre-seed stages, which generally involves smaller initial investments aimed at supporting early growth.
What kind of post-investment involvement does Cure Kids Ventures have?
Cure Kids Ventures provides its portfolio companies with industry-specific expertise, access to networks, and ongoing support to help them scale and succeed in the healthcare market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.